Know More About This Test

Anti-Cardiolipin Antibodies (IgM) are autoantibodies associated with Antiphospholipid Syndrome (APS), a condition that increases the risk of abnormal blood clots and recurrent pregnancy loss. This test helps identify autoimmune-related clotting disorders by detecting these specific antibodies in the blood. Persistent positivity on repeat testing indicates APS, while transient positivity may occur during infections.

Why Is This Test Recommended?

Anti-Cardiolipin Antibodies (IgM) testing is recommended to evaluate unexplained thrombosis, investigate recurrent miscarriages, and diagnose autoimmune clotting disorders. It is used to assess stroke or deep vein thrombosis (DVT) in young patients without traditional risk factors. The test helps identify individuals at risk for thrombotic complications and pregnancy-related complications associated with Antiphospholipid Syndrome.

What Do the Results Indicate?

Negative results suggest no evidence of Antiphospholipid Syndrome. Persistent positive results (confirmed on repeat testing at least 12 weeks apart) indicate APS is likely and require clinical correlation with symptoms. Transient positive results may occur during acute infections and do not necessarily indicate APS. Diagnosis requires both positive laboratory findings and compatible clinical features such as thrombosis or pregnancy complications.

How Is the Test Performed and Prepared For?

A blood sample is collected through standard venipuncture for laboratory analysis. No fasting is required for this test. Avoid testing during acute infection as it may cause transient false-positive results. If initial results are positive, repeat testing after 12 weeks is essential to confirm persistent positivity before diagnosing Antiphospholipid Syndrome.

Frequently Asked Questions (FAQs)

• Is one positive test enough?
  No, repeat needed; APS diagnosis requires positive results on at least two occasions, 12 weeks or more apart, to confirm persistent antibody presence.

• Is APS treatable?
  Yes, with anticoagulation; treatment typically involves anticoagulant medications like aspirin or warfarin to prevent clotting, with specific protocols during pregnancy.

• Can infections cause false positives?
  Yes; acute viral or bacterial infections can temporarily elevate antibody levels, which is why confirmation testing after recovery is important.

• Is this test used in pregnancy?
  Yes; it is commonly ordered in cases of recurrent miscarriage, unexplained pregnancy loss, or complications like preeclampsia or placental insufficiency.

• Is lifelong treatment required?
  Sometimes; patients with confirmed APS and history of thrombosis typically require long-term anticoagulation, while others may need treatment only during high-risk periods.